Pegylated interferon alfa 2b (PEG-IFN) and ribavirin for hepatitis C patients who were nonresponders to previous therapy

被引：0
|
作者：
Lawitz, EJ
Cantu, NS
Becker, S
Dhar, R
Li, J
Bala, NS
Gordon, S
Davis, M
Nader, P
Holtzmuller, K
Rosenfield, T
Monsour, H
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
80
引用
收藏
页码：A626 / A626
页数：1
相关论文
共 50 条
  • [1] Pegylated interferon alfa 2b and ribavirin for hepatitis C patients who were nonresponders to previous
    Lawitz, EJ
    Bala, NS
    Becker, S
    Brown, G
    Davis, M
    Dhar, R
    Ganeshappa, KP
    Gordon, S
    Holtzmuller, K
    Jeffries, M
    Li, JJ
    Monsour, H
    Nader, P
    Rosenfield, T
    Tolman, K
    Kadakia, S
    GASTROENTEROLOGY, 2003, 124 (04) : A783 - A784
  • [2] Pegylated interferon alfa 2b (PEG-IFN) and ribavirin for hepatitis C patients who were previous nonresponders to standard combination therapy: 24 week viral clearance.
    Lawitz, EJ
    Jeffries, MA
    Cantu, NS
    Kadakia, SC
    HEPATOLOGY, 2001, 34 (04) : 338A - 338A
  • [3] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 (7) : 2009 - 2009
  • [4] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
  • [5] Consensus interferon and ribavirin in patients with chronic hepatitis c who were nonresponders to pegylated interferon alfa-2b and ribavirin
    Leevy, Carroll B.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1961 - 1966
  • [6] Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to prior therapy with either interferon alfa and ribavirin or pegylated interferon and ribavirin
    Chen, K
    Seraphin, P
    Murphy, L
    Shah, N
    HEPATOLOGY, 2005, 42 (04) : 670A - 670A
  • [7] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [8] Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
    Sandoughdaran, Saleh
    Alavian, Seyed Moayed
    Sharafi, Heidar
    Behnava, Bita
    Salimi, Shima
    Mehrnoush, Leila
    Elizee, Pegah Karimi
    Keshvari, Maryam
    HEPATITIS MONTHLY, 2015, 15 (01)
  • [9] Treatment of chronic hepatitis C in HIV infected patients (pts) with pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b
    Cargnel, A
    Angeli, E
    Mainini, A
    Casella, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, PG
    JOURNAL OF HEPATOLOGY, 2003, 38 : 132 - 132
  • [10] Triple therapy compared to standard Pegylated Interferon Alfa 2b plus weight based Ribavirin for previous nonresponders and relapsers with chronic hepatitis C.
    Lawitz, EJ
    Cantu, NS
    Davis, M
    Afdhal, N
    Curry, M
    Mailliard, M
    Adams, F
    Tsai, N
    Gasic, A
    Kothari, T
    Ganeshappa, KP
    Cox, J
    Silverman, B
    Kadakia, SC
    HEPATOLOGY, 2003, 38 (04) : 742A - 742A
12345